ARCHIVES

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

This article is from The Cancer Letter archive.

Vol. 09 No. 01 | January 7, 1983

Download PDF Visit The Full Archive

Related Articles

NCI To Appoint Expert Group To Consider Standards For Outcomes Measurement.

September 29, 2000

Volasertib and LDAC Doubled Response in Older Patients

July 25, 2014

US Oncology To Participate In Firm’s Ovarian Cancer Trial.

January 26, 2001

Clinical Trials Approved By NCI

November 26, 2010

Eight Centers Picked To Host Regional Breast Cancer Summits

January 31, 1992

Is $45 Million Too Much to Spend on PR? NCAB Panel Weighs NCI Communications Budget

December 7, 2012